The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrations

被引:4
作者
Ottaggio, Laura [1 ]
Zunino, Annalisa [1 ]
Maric, Irena [2 ]
Grozio, Alessia [2 ]
Rossi, Edoardo [3 ]
Spriano, Mauro [3 ]
Viaggi, Silvia [1 ,2 ]
机构
[1] Natl Inst Canc Res, IST, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Biol, Genoa, Italy
[3] San Martino Hosp, Genoa, Italy
关键词
B-CLL; chromosome aberrations; centrosomes; prognostic markers;
D O I
10.1002/hon.838
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome aberrations are frequently found in B-cell chronic lymphocytic leukaemia (B-CLL), and specific chromosome aberrations identify poor prognostic subgroups. Almost all the aberrations identified in B-CLL involve loci where genes with a role in the regulation of centrosome duplication have been mapped. Centrosome aberrations have been described as a possible cause of numerical chromosome abnormalities in both solid and haematological tumours. However, little is known about the possible role of centrosome aberrations in B-CLL. To investigate whether centrosome aberrations do occur in B-CLL and correlate with cytogenetically defined prognostic subgroups, we examined a set of 64 B-CLL samples by immunofluorescent staining. B-CLL cases differed significantly from controls in the mean frequency of cells with centrosome aberrations, while no difference was found between subgroups with or without specific chromosome aberrations. Our results indicated that although centrosome aberrations were a common feature in B-CLL, they did not represent a reliable prognostic marker. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 17 条
[1]   COMPARATIVE GENOMIC HYBRIDIZATION IN CHRONIC B-CELL LEUKEMIAS SHOWS A HIGH-INCIDENCE OF CHROMOSOMAL GAINS AND LOSSES [J].
BENTZ, M ;
HUCK, K ;
DUMANOIR, S ;
JOOS, S ;
WERNER, CA ;
FISCHER, K ;
DOHNER, H ;
LICHTER, P .
BLOOD, 1995, 85 (12) :3610-3618
[2]  
CHIORAZZI N, 2006, HEMATOL-AM SOC HEMAT, V512, P273
[3]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[4]   QUANTITATIVE-ANALYSIS OF COMPARATIVE GENOMIC HYBRIDIZATION [J].
DUMANOIR, S ;
SCHROCK, E ;
BENTZ, M ;
SPEICHER, MR ;
JOOS, S ;
RIED, T ;
LICHTER, P ;
CREMER, T .
CYTOMETRY, 1995, 19 (01) :27-41
[5]   Centrosome amplification, chromosome instability and cancer development [J].
Fukasawa, K .
CANCER LETTERS, 2005, 230 (01) :6-19
[6]   High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia [J].
Hensel, Manfred ;
Zoz, Martin ;
Giesecke, Christian ;
Benner, Axel ;
Neben, Kai ;
Jauch, Anna ;
Stilgenbauer, Stephan ;
Ho, Anthony D. ;
Kraemer, Alwin .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :978-983
[7]   Two for two: Cdk2 and its role in centrosome doubling [J].
Hinchcliffe, EH ;
Sluder, G .
ONCOGENE, 2002, 21 (40) :6154-6160
[8]  
Karhu R, 1997, GENE CHROMOSOME CANC, V19, P286, DOI 10.1002/(SICI)1098-2264(199708)19:4<286::AID-GCC12>3.0.CO
[9]  
2-E
[10]   Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure [J].
Kawamura, K ;
Morita, N ;
Domiki, C ;
Fujikawa-Yamamoto, K ;
Hashimoto, M ;
Iwabuchi, K ;
Suzuki, K .
CANCER SCIENCE, 2006, 97 (04) :252-258